Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Hokibara

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Rheumatology|March 14, 2014
Markedly elevated CD64 expressions on neutrophils and monocytes are useful for diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome during flaresTakashi Yamazaki, Sho Hokibara, Tomonari Shigemura, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 30, 2016
Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki diseaseSho Hokibara, Norimoto Kobayashi, Keiko Kobayashi, et al.
Human Immunology|June 11, 2013
Increased CD45RO+ CD62L+ CD4+ T-cell subpopulation responsible for Th2 response in Kimura's diseaseKazuko Yamazaki, Hisashi Kawashima, Satoshi Sato, et al.
Blood|January 10, 2002
The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cellsHaruo Nagumo, Kazunaga Agematsu, Norimoto Kobayashi, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2002
Absence of memory B cells in patients with common variable immunodeficiencyKazunaga Agematsu, Takeshi Futatani, Sho Hokibara, et al.
Pediatric Cardiology|June 4, 2026
Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe DyslipidemiaYuto Sunaga, Yohei Hasebe, Masashi Yoshizawa, et al.
Journal of Epidemiology|September 6, 2021
Prevention Measures for COVID-19 and Changes in Kawasaki Disease IncidenceNobuyuki Katsumata, Daisuke Harama, Takako Toda, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|March 14, 2014
Markedly elevated CD64 expressions on neutrophils and monocytes are useful for diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome during flaresTakashi Yamazaki, Sho Hokibara, Tomonari Shigemura, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 30, 2016
Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki diseaseSho Hokibara, Norimoto Kobayashi, Keiko Kobayashi, et al.
Human Immunology|June 11, 2013
Increased CD45RO+ CD62L+ CD4+ T-cell subpopulation responsible for Th2 response in Kimura's diseaseKazuko Yamazaki, Hisashi Kawashima, Satoshi Sato, et al.
Blood|January 10, 2002
The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cellsHaruo Nagumo, Kazunaga Agematsu, Norimoto Kobayashi, et al.
Clinical Immunology (Orlando, Fla.)|May 4, 2002
Absence of memory B cells in patients with common variable immunodeficiencyKazunaga Agematsu, Takeshi Futatani, Sho Hokibara, et al.
Pediatric Cardiology|June 4, 2026
Infliximab as an Effective Second-Line Treatment for IVIG-Resistant Kawasaki Disease Accompanied by Severe DyslipidemiaYuto Sunaga, Yohei Hasebe, Masashi Yoshizawa, et al.
Journal of Epidemiology|September 6, 2021
Prevention Measures for COVID-19 and Changes in Kawasaki Disease IncidenceNobuyuki Katsumata, Daisuke Harama, Takako Toda, et al.
Pageof 1